Vera Therapeutics is trading at $30.38, up 5.16% in after-hours trading, in a move consistent with stronger risk appetite; no new company-specific announcement was found on August 13, 2026 to directly explain the gain.
- The S&P 500 rose 0.72% and Nasdaq Composite gained 0.98% following cooler inflation data.
- The August 10 earnings update and TRUTAKNA launch remain relevant background, but are not fresh catalysts.
- Confidence in the explanation is medium-low.